Lufax IPO Valuation: The Risk-Reward Profile Does Not Justify the Premium
In this insight, we evaluate the attractiveness of Lufax's IPO valuation compared to its peers. We believe the company shares are overvalued and...
511 Views
ECM Weekly (25 October 2020) - Ant Group, Lufax, JW Thera, Shimao Svcs, GDS Secondary, Nanofilm
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
737 Views
Lufax IPO: Valuation Insights
Our valuation analysis suggests that the IPO price range is unattractive and we would be inclined to give the IPO a pass.
859 Views
Lufax IPO - Stuck with the Earlier Fundraising Valuation
Lufax Holdings (LU US) aims to raise around US$2.4bn via its US listing. The company is backed by Ping An Insurance and has undergone major changes...
586 Views
Lufax Pre-IPO - Peer Review - Bigger than Antās CreditTech, in Revenue
Lufax Holdings (LU US) aims to raise around US$3bn via its US listing. The company is backed by Ping An Insurance (2318 HK).
654 Views